Nutranomics Acquires Worldwide Exclusive Licence to GenEpic Prostate Cancer Treatment

Nutranomics (OTC: NNRX ) is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC ("Genesar") to acquire the worldwide exclusive marketing and distributing rights to GenEpic™, a natural therapeutic treatment formula currently the subject of an IRB reviewed (FDA regulated) phase II human